Citations (57)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Wanyi Liu, Guicheng Kuang, Binbin Yang, Hanlin Liu, Yangping Lv, Yang Xiong & Yongqiu Zeng. (2023) Progress on the role and mechanism of ribosome assembly regulator PNO1 in tumor. All Life 16:1.
Read now
Read now
Alaa A.-M. Abdel-Aziz, Adel S. El-Azab, Nawaf A. AlSaif, Ahmad J. Obaidullah, Abdulrahman M. Al-Obaid & Ibrahim A. Al-Suwaidan. (2021) Synthesis, potential antitumor activity, cell cycle analysis, and multitarget mechanisms of novel hydrazones incorporating a 4-methylsulfonylbenzene scaffold: a molecular docking study. Journal of Enzyme Inhibition and Medicinal Chemistry 36:1, pages 1520-1538.
Read now
Read now
Walaa M. El-Husseiny, Magda A.-A. El-Sayed, Adel S. El-Azab, Nawaf A. AlSaif, Mohammed M. Alanazi & Alaa A.-M. Abdel-Aziz. (2020) Synthesis, antitumor activity, and molecular docking study of 2-cyclopentyloxyanisole derivatives: mechanistic study of enzyme inhibition. Journal of Enzyme Inhibition and Medicinal Chemistry 35:1, pages 744-758.
Read now
Read now
Jennifer Bourn & Maria Cekanova. (2018) Cyclooxygenase inhibitors potentiate receptor tyrosine kinase therapies in bladder cancer cells in vitro. Drug Design, Development and Therapy 12, pages 1727-1742.
Read now
Read now
Pingting Zhou, Yanyan Li, Bo Li, Meichao Zhang, Ci Xu, Furao Liu, Lei Bian, Yuanhua Liu, Yuan Yao & Dong Li. (2018) Autophagy inhibition enhances celecoxib-induced apoptosis in osteosarcoma. Cell Cycle 17:8, pages 997-1006.
Read now
Read now
Miklos Gulyas, Johanna Sofia Margareta Mattsson, Andrea Lindgren, Lars Ek, Kristina Lamberg Lundström, Annelie Behndig, Erik Holmberg, Patrick Micke & Bengt Bergman. (2018) COX-2 expression and effects of celecoxib in addition to standard chemotherapy in advanced non-small cell lung cancer. Acta Oncologica 57:2, pages 244-250.
Read now
Read now
Koh Miura, Masayuki Satoh, Makoto Kinouchi, Kuniharu Yamamoto, Yasuhiro Hasegawa, Yoichiro Kakugawa, Masaaki Kawai, Kiyoshi Uchimi, Hiroki Aizawa, Shinobu Ohnuma, Taiki Kajiwara, Hiroto Sakurai & Tsuneaki Fujiya. (2015) The use of natural products in colorectal cancer drug discovery. Expert Opinion on Drug Discovery 10:4, pages 411-426.
Read now
Read now
Daniel Gonnermann, Hans-Heinrich Oberg, Christian Kellner, Matthias Peipp, Susanne Sebens, Dieter Kabelitz & Daniela Wesch. (2015) Resistance of cyclooxygenase-2 expressing pancreatic ductal adenocarcinoma cells against γδ T cell cytotoxicity. OncoImmunology 4:3.
Read now
Read now
Articles from other publishers (49)
Hai-Anh Ha, Latifah A. Al-Humaid, Majdoleen Aldawsari, Devaraj Bharathi & Jintae Lee. (2023) Evaluation of phytochemical, antibacterial, thrombolytic, anti-inflammatory, and cytotoxicity profile of Achyranthes aspera aerial part extracts. Environmental Research, pages 117802.
Crossref
Crossref
Adrián Povo-Retana, Sergio Sánchez-García, Carlota Alvarez-Lucena, Rodrigo Landauro-Vera, Patricia Prieto, Carmen Delgado, Paloma Martín-Sanz & Lisardo Boscá. (2023) Crosstalk between P2Y receptors and cyclooxygenase activity in inflammation and tissue repair. Purinergic Signalling.
Crossref
Crossref
Adel S. El-Azab, Hamad M. Alkahtani, Nawaf A. AlSaif, Ibrahim A. Al-Suwaidan, Ahmad J. Obaidullah, Mohammed M. Alanazi, Abdulrahman M. Al-Obaid, Mohamed H.M. Al-Agamy & Alaa A.-M. Abdel-Aziz. (2023) Synthesis, antiproliferative and enzymatic inhibition activities of quinazolines incorporating benzenesulfonamide: Cell cycle analysis and molecular modeling study. Journal of Molecular Structure 1278, pages 134928.
Crossref
Crossref
Noor ul Amin Mohsin, Sana Aslam, Matloob Ahmad, Muhammad Irfan, Sami A. Al-Hussain & Magdi E. A. Zaki. (2022) Cyclooxygenase-2 (COX-2) as a Target of Anticancer Agents: A Review of Novel Synthesized Scaffolds Having Anticancer and COX-2 Inhibitory Potentialities. Pharmaceuticals 15:12, pages 1471.
Crossref
Crossref
Masoumeh Kiani-Zadeh, Mohammad Reza Rezvany, Soodeh Namjoo, Mahmood Barati, Mohammad Hossein Mohammadi, Bahare Ghasemi, Tahere Tabatabaei, Ardeshir Ghavamzadeh, Farhad Zaker & Ladan Teimoori-Toolabi. (2022) Studying the potential of upregulated PTGS2 and VEGF-C besides hyper-methylation of PTGS2 promoter as biomarkers of Acute myeloid leukemia. Molecular Biology Reports 49:8, pages 7849-7862.
Crossref
Crossref
Mohammad Taleb, Niloufar Mohammadkhani, Farbod Bahreini, Muhammad Ovais & Guangjun Nie. (2022) Modulation of Tumor Vasculature Network: Key Strategies. Small Structures 3:6.
Crossref
Crossref
Colin A. Bill, Christopher M. Allen & Charlotte M. Vines. (2022) C-C Chemokine Receptor 7 in Cancer. Cells 11:4, pages 656.
Crossref
Crossref
Deivasigamani Priya, Papichettypalle Gopinath, Loganathan Sumathi Dhivya, Anandan Vijaybabu, Manoharan Haritha, Senthilkumar Palaniappan & Muthu K. Kathiravan. (2022) Structural Insights into Pyrazoles as Agents against Anti‐inflammatory and Related Disorders. ChemistrySelect 7:5.
Crossref
Crossref
Sandra Ramos-Inza, Ana Carolina Ruberte, Carmen Sanmartín, Arun K. Sharma & Daniel Plano. (2021) NSAIDs: Old Acquaintance in the Pipeline for Cancer Treatment and Prevention─Structural Modulation, Mechanisms of Action, and Bright Future. Journal of Medicinal Chemistry 64:22, pages 16380-16421.
Crossref
Crossref
Ángela Alonso-Diez, Sara Cáceres, Laura Peña, Belén Crespo & Juan Carlos Illera. (2021) Anti-Angiogenic Treatments Interact with Steroid Secretion in Inflammatory Breast Cancer Triple Negative Cell Lines. Cancers 13:15, pages 3668.
Crossref
Crossref
Xiaoliang Cheng, Ling Zhao, Tingyu Ke, Xi Wang, Lijun Cao, Shuyan Liu, Jie He & Wei Rong. (2021) Celecoxib ameliorates diabetic neuropathy by decreasing apoptosis and oxidative stress in dorsal root ganglion neurons via the miR‑155/COX‑2 axis. Experimental and Therapeutic Medicine 22:2.
Crossref
Crossref
Shahin Boumi, Jafar Moghimirad, Seyed Nasser Ostad, Massoud Amanlou, Shohreh Tavajohi & Mohsen Amini. (2020) Synthesis, Biological Evaluation and Docking Study of New Pyrimidine Compounds as Anticancer Agents. Drug Research 71:05, pages 284-290.
Crossref
Crossref
Shahin Boumi, Jafar Moghimirad, Massoud Amanlou, Seyed Nasser Ostad, Shohreh Tavajohi & Mohsen Amini. (2021) Synthesis, Evaluation of Biological Activity, Docking and Molecular Dynamic Studies of Pyrimidine Derivatives. Letters in Organic Chemistry 18:3, pages 212-225.
Crossref
Crossref
Chu-Yun Lin, Jung-Yu Lee, Sing-Han Huang, Yen-Chao Hsu, Nung-Yu Hsu & Jinn-Moon Yang. (2020) FooDisNET: a database of food-compound-protein-disease associations. FooDisNET: a database of food-compound-protein-disease associations.
Rikki A. M. Brown, Kirsty L. Richardson, Tasnuva D. Kabir, Debbie Trinder, Ruth Ganss & Peter J. Leedman. (2020) Altered Iron Metabolism and Impact in Cancer Biology, Metastasis, and Immunology. Frontiers in Oncology 10.
Crossref
Crossref
C-C Sim & E U-H Sim. (2020) Over-expression of cyclo-oxygenase-2 predicts poor survival of patients with nasopharyngeal carcinoma: a meta-analysis. The Journal of Laryngology & Otology 134:4, pages 338-343.
Crossref
Crossref
Debjani Dasgupta, Manan Desai, Shubham Waichal & Pramodkumar P. Gupta. (2020) Molecular Docking Based Study and Analysis of Phytochemicals with
TNF-α in Search of Anti-Inflammatory and Anticancer Agents. Asian Journal of Organic & Medicinal Chemistry 5:2, pages 109-112.
Crossref
Crossref
Süreyya Ölgen. 2020. Drug Repurposing in Cancer Therapy. Drug Repurposing in Cancer Therapy
395
437
.
João Basso, Maria Mendes, Ana Fortuna, Rui Vitorino, João Sousa, Alberto Pais & Carla Vitorino. 2020. Drug Repurposing in Cancer Therapy. Drug Repurposing in Cancer Therapy
353
393
.
George Mattheolabakis & Constantinos M. Mikelis. (2019) Nanoparticle Delivery and Tumor Vascular Normalization: The Chicken or The Egg?. Frontiers in Oncology 9.
Crossref
Crossref
Navneet Kishore, Pradeep Kumar, Karuna Shanker & Akhilesh Kumar Verma. (2019) Human disorders associated with inflammation and the evolving role of natural products to overcome. European Journal of Medicinal Chemistry 179, pages 272-309.
Crossref
Crossref
Doaa Tawfik, Christopher Groth, Jan-Paul Gundlach, Matthias Peipp, Dieter Kabelitz, Thomas Becker, Hans-Heinrich Oberg, Anna Trauzold & Daniela Wesch. (2019) TRAIL-Receptor 4 Modulates γδ T Cell-Cytotoxicity Toward Cancer Cells. Frontiers in Immunology 10.
Crossref
Crossref
Xiao-Qiang Yan, Zhong-Chang Wang, Bo Zhang, Peng-Fei Qi, Gui-Gen Li & Hai-Liang Zhu. (2019) Dihydropyrazole Derivatives Containing Benzo Oxygen Heterocycle and Sulfonamide Moieties Selectively and Potently Inhibit COX-2: Design, Synthesis, and Anti-Colon Cancer Activity Evaluation. Molecules 24:9, pages 1685.
Crossref
Crossref
Alaa A.-M. Abdel-Aziz, Andrea Angeli, Adel S. El-Azab, Mohammed E.A. Hammouda, Magda A. El-Sherbeny & Claudiu T. Supuran. (2019) Synthesis and anti-inflammatory activity of sulfonamides and carboxylates incorporating trimellitimides: Dual cyclooxygenase/carbonic anhydrase inhibitory actions. Bioorganic Chemistry 84, pages 260-268.
Crossref
Crossref
Natalia Tołoczko-Iwaniuk, Dorota Dziemiańczyk-Pakieła, Beata Klaudia Nowaszewska, Katarzyna Celińska-Janowicz & Wojciech Miltyk. (2019) Celecoxib in Cancer Therapy and Prevention – Review. Current Drug Targets 20:3, pages 302-315.
Crossref
Crossref
Rafael I Jaén, Patricia Prieto, Marta Casado, Paloma Martín-Sanz & Lisardo Boscá. (2018) Post-translational modifications of prostaglandin-endoperoxide synthase 2 in colorectal cancer: An update. World Journal of Gastroenterology 24:48, pages 5454-5461.
Crossref
Crossref
Wesam Ali, Mónica Álvarez-Pérez, Małgorzata Anna Marć, Noemi Salardón-Jiménez, Jadwiga Handzlik & Enrique Domínguez-Álvarez. (2018) The Anticancer and Chemopreventive Activity of Selenocyanate-Containing Compounds. Current Pharmacology Reports 4:6, pages 468-481.
Crossref
Crossref
Walaa M. El-Husseiny, Magda A.-A. El-Sayed, Naglaa I. Abdel-Aziz, Adel S. El-Azab, Yousif A. Asiri & Alaa A.-M. Abdel-Aziz. (2018) Structural alterations based on naproxen scaffold: Synthesis, evaluation of antitumor activity and COX-2 inhibition, and molecular docking. European Journal of Medicinal Chemistry 158, pages 134-143.
Crossref
Crossref
Jayoung Kim, Seung-Woo Hong, Seonghan Kim, Daejin Kim, Dae Hur, Dong-Hoon Jin, Bomi Kim & Yeong Kim. (2017) Cyclooxygenase-2 expression is induced by celecoxib treatment in lung cancer cells and is transferred to neighbor cells via exosomes. International Journal of Oncology.
Crossref
Crossref
Guanhua Zhang & Ye-Hua Gan. (2017) Synergistic antitumor effects of the combined treatment with an HDAC6 inhibitor and a COX-2 inhibitor through activation of PTEN. Oncology Reports 38:5, pages 2657-2666.
Crossref
Crossref
Bo Li, Xinzhe Li, Haojun Xiong, Peng Zhou, Zhenhong Ni, Teng Yang, Yan Zhang, Yijun Zeng, Jintao He, Fan Yang, Nan Zhang, Yuting Wang, Yingru Zheng & Fengtian He. (2017) Inhibition of COX2 enhances the chemosensitivity of dichloroacetate in cervical cancer cells. Oncotarget 8:31, pages 51748-51757.
Crossref
Crossref
Adnan A Bekhit, Ahmed M Farghaly, Ragab M Shafik, Mona MA Elsemary, Mai S El-Shoukrofy, Alaa El-Din A Bekhit & Tamer M Ibrahim. (2017) Synthesis, evaluation and modeling of some triazolothienopyrimidinones as anti-inflammatory and antimicrobial agents. Future Medicinal Chemistry 9:9, pages 881-897.
Crossref
Crossref
Atul Bhardwaj, Jatinder Kaur, Melinda Wuest & Frank Wuest. (2017) In situ click chemistry generation of cyclooxygenase-2 inhibitors. Nature Communications 8:1.
Crossref
Crossref
Bomi KimJayoung KimYeong Seok Kim. (2017) Celecoxib induces cell death on non-small cell lung cancer cells through endoplasmic reticulum stress. Anatomy & Cell Biology 50:4, pages 293.
Crossref
Crossref
Manoj Kumar, Sunil Kumar Dhatwalia & D. K. Dhawan. (2016) Role of angiogenic factors of herbal origin in regulation of molecular pathways that control tumor angiogenesis. Tumor Biology 37:11, pages 14341-14354.
Crossref
Crossref
Guido Bocci, Esther K. Lee, Anthony J. Mutsaers & Urban Emmenegger. 2016. Animal Models for Human Cancer. Animal Models for Human Cancer
223
246
.
Bin Yang, Lin Jia, Qiaojuan Guo, Hui Ren, Yanping Hu & Tao Xie. (2016) Clinicopathological and prognostic significance of cyclooxygenase-2 expression in head and neck cancer: A meta-analysis. Oncotarget 7:30, pages 47265-47277.
Crossref
Crossref
Anuj Suri, Xiugui Sheng, Kevin M. Schuler, Yan Zhong, Xiaoyun Han, Hannah M. Jones, Paola A. Gehrig, Chunxiao Zhou & Victoria L. Bae-Jump. (2016) The effect of celecoxib on tumor growth in ovarian cancer cells and a genetically engineered mouse model of serous ovarian cancer. Oncotarget 7:26, pages 39582-39594.
Crossref
Crossref
Belgin Sever, Mehlika Dilek Altıntop, Gökhan Kuş, Mete Özkurt, Ahmet Özdemir & Zafer Asım Kaplancıklı. (2016) Indomethacin based new triazolothiadiazine derivatives: Synthesis, evaluation of their anticancer effects on T98 human glioma cell line related to COX-2 inhibition and docking studies. European Journal of Medicinal Chemistry 113, pages 179-186.
Crossref
Crossref
Bingfei Xu, Yu Wang, Jing Yang, Zhengfeng Zhang, Ying Zhang & Hansong Du. (2016) Celecoxib induces apoptosis but up-regulates VEGF via endoplasmic reticulum stress in human colorectal cancer in vitro and in vivo. Cancer Chemotherapy and Pharmacology 77:4, pages 797-806.
Crossref
Crossref
Han-Yue Qiu, Peng-Fei Wang, Zhen Li, Jun-Ting Ma, Xiao-Ming Wang, Yong-Hua Yang & Hai-Liang Zhu. (2016) Synthesis of dihydropyrazole sulphonamide derivatives that act as anti-cancer agents through COX-2 inhibition. Pharmacological Research 104, pages 86-96.
Crossref
Crossref
Ruud Weijer, Mans Broekgaarden, Rowan F. van Golen, Esther Bulle, Esther Nieuwenhuis, Aldo Jongejan, Perry D. Moerland, Antoine H. C. van Kampen, Thomas M. van Gulik & Michal Heger. (2015) Low-power photodynamic therapy induces survival signaling in perihilar cholangiocarcinoma cells. BMC Cancer 15:1.
Crossref
Crossref
Yanmei Zhang, Micky D. Tortorella, Jinxi Liao, Xiaochu Qin, Tingting Chen, Jinfeng Luo, Jiantong Guan, John J. Talley & Zhengchao Tu. (2015) Synthesis and Evaluation of Novel Erlotinib–NSAID Conjugates as More Comprehensive Anticancer Agents. ACS Medicinal Chemistry Letters 6:10, pages 1086-1090.
Crossref
Crossref
Hongzhong Li, Bing Yang, Jing Huang, Yong Lin, Tingxiu Xiang, Jingyuan Wan, Hongyuan Li, Salem Chouaib & Guosheng Ren. (2015) Cyclooxygenase-2 in tumor-associated macrophages promotes breast cancer cell survival by triggering a positive-feedback loop between macrophages and cancer cells. Oncotarget 6:30, pages 29637-29650.
Crossref
Crossref
Gábor Boros, Edit Miko, Hiromi Muramatsu, Drew Weissman, Eszter Emri, Gijsbertus T. J. van der Horst, Andrea Szegedi, Irén Horkay, Gabriella Emri, Katalin Karikó & Éva Remenyik. (2015) Identification of Cyclobutane Pyrimidine Dimer-Responsive Genes Using UVB-Irradiated Human Keratinocytes Transfected with In Vitro-Synthesized Photolyase mRNA. PLOS ONE 10:6, pages e0131141.
Crossref
Crossref
Laurence Booth, Jane L. Roberts, Nichola Cruickshanks, Seyedmehrad Tavallai, Timothy Webb, Peter Samuel, Adam Conley, Brittany Binion, Harold F. Young, Andrew Poklepovic, Sarah Spiegel & Paul Dent. (2015) PDE5 Inhibitors Enhance Celecoxib Killing in Multiple Tumor Types. Journal of Cellular Physiology 230:5, pages 1115-1127.
Crossref
Crossref
Muhammad Waqas Usman, Fuwen Luo, Hailing Cheng, Jean J. Zhao & Pixu Liu. (2015) Chemopreventive effects of aspirin at a glance. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1855:2, pages 254-263.
Crossref
Crossref
Sepp R. Jansen, Rian Holman, Ilja Hedemann, Ewoud Frankes, Carolina R. S. Elzinga, Wim Timens, Reinoud Gosens, Eveline S. de Bont & Martina Schmidt. (2015)
Prostaglandin E
2
promotes
MYCN
non-amplified neuroblastoma cell survival
via
β-catenin stabilization
. Journal of Cellular and Molecular Medicine 19:1, pages 210-226.
Crossref
Crossref
Janice E. Drew, Andrew J. Farquharson, Graham W. Horgan, Susan J. Duthie & Garry G. Duthie. (2014) Postprandial cell defense system responses to meal formulations: Stratification through gene expression profiling. Molecular Nutrition & Food Research 58:10, pages 2066-2079.
Crossref
Crossref